Effects of Biofeedback on Somatic Symptoms
1 other identifier
observational
20
1 country
1
Brief Summary
Biofeedback is a therapeutic paradigm that teaches patients how to gain awareness and control over previously unrecognized sympathetic changes such as body temperature, blood pressure, and heart rate. We propose to use a six session biofeedback protocol that includes heart-rate variability (HRV) biofeedback, respiration/relaxation training, and body temperature control to treat UCLA patients with chronic medical conditions (e.g. pulmonary, neurology) and somatic symptoms (pain, psychosomatic non-epileptic seizures, panic attacks, long-COVID symptoms). The aim of the study is to determine whether patients who complete a six-session biofeedback protocol report a decrease in somatic symptoms, and improvements in self-rated mental health (depression, anxiety, quality of life) after the program and at three-months follow-up. The investigators will also study whether these improvements are also related to reduced healthcare utilization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 13, 2021
CompletedFirst Posted
Study publicly available on registry
November 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedOctober 3, 2024
October 1, 2024
3 years
September 13, 2021
October 2, 2024
Conditions
Outcome Measures
Primary Outcomes (7)
Change in depression score on the PHQ-9
Improvement in self-rated depressive sx on the PHQ-9
3 months and 6 months
Change in quality of life (QOL)
Improvement in self-rated QOL on the SF-36
3 months and 6 months
Change in anxiety
Improvement in self-rated anxiety sx on the GAD-7
3 months and 6 months
Reduced physical symptoms
Improvement in self-rated physical symptoms on the PHQ-15
3 months and 6 months
Improved self-efficacy
Improvement in self-rated self-efficacy on the Self-efficacy for Managing Chronic Disease 6-item Scale
3 months and 6 months
Reduced health anxiety
Reduced scores on the self-reported Health Anxiety Inventory
3 months and 6 months
Improved sleep
Improved sleep and reduced insomnia on the PSQI
3 months and 6 months
Secondary Outcomes (1)
Reduced healthcare utilization
3 months and 6 months
Study Arms (2)
Immediate enrollment
Wait-list controls
Interventions
We propose to study whether patients who complete a clinical six-session biofeedback protocol will demonstrate improvements in mental and physical health.
Eligibility Criteria
(1) participants must be between 15-60; (2) English speaking; (3) minor participants must have one parent consent to research and treatment; (4) participants must have at least one qualifying somatic complaint (seizure-like spells, pain, nausea) or have psychosocial distress related to the management of their medical conditions (comorbid panic attacks, low mood, etc.).
You may qualify if:
- between 15-60 years of age
- English speaking
- minor participants must have one parent consent to research and treatment
- must have at least one qualifying somatic complaint (seizure-like spells, pain, nausea) or have psychosocial distress related to the management of their medical conditions (comorbid panic attacks, low mood, etc.).
You may not qualify if:
- severe psychopathology (e.g., psychosis, active suicidality, moderate to severe intellectual impairment).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA
Los Angeles, California, 90095, United States
Related Publications (1)
Emerson ND, Lavretsky H, Pittman WQ, Viswanathan N, Siddarth P. An open trial of biofeedback for long COVID. J Psychosom Res. 2024 Apr;179:111625. doi: 10.1016/j.jpsychores.2024.111625. Epub 2024 Feb 23.
PMID: 38458016DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Clinical Professor
Study Record Dates
First Submitted
September 13, 2021
First Posted
November 15, 2021
Study Start
September 1, 2021
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
October 3, 2024
Record last verified: 2024-10